合成橡膠輸液幫浦市場規模、佔有率、成長分析、按產品、按應用、按最終用途、按地區 - 產業預測，2024-2031 年

2022年，全球合成橡膠輸液幫浦市場規模將達到6.38億美元，從2023年的6.8457億美元成長到2031年的12.0287億美元，預計在預測期內（2024年~2031年）成長。 7.30%。

由於多種因素的綜合作用凸顯了對先進醫療輸送系統的需求不斷成長，全球合成橡膠輸液幫浦市場預計將顯著成長。整形外科手術和手術數量的增加、對緊湊型一次性門診合成橡膠輸液幫浦的需求不斷成長以及技術的快速進步正在促進市場擴張。值得注意的是，慢性病，特別是糖尿病的盛行率正在增加。國際糖尿病聯盟最近的統計數據顯示，糖尿病患者數量驚人增加，預測到 2030 年，大約有 6.43 億成年人將受到這種疾病的影響。據世界衛生組織 (WHO) 稱，此類慢性疾病每年導致 4,100 萬人死亡，凸顯了有效管理解決方案的迫切需求。此外，骨髓炎等疾病呈上升趨勢，在美國每年報告約 50,000 例病例，特別是在患有糖尿病和周圍血管疾病等併發症的人群中。慢性疾病負擔的迅速增加正在推動對安全有效的靜脈給藥的需求，從而推動合成橡膠輸液幫浦市場的發展。隨著醫療保健系統越來越重視改善患者治療效果和採用創新技術，美國合成橡膠輸液幫浦市場預計將在未來的預測期內實現永續年成長率。這一趨勢反映了醫療設備業相關人員加強患者照護並滿足醫療保健提供者不斷變化的需求的重大機會。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 次要/一級資訊來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 技術分析
• 價值鏈分析
• 市場生態系統
• 案例研究分析
• 監管環境
• 創新矩陣
• 重點投資分析
• 關鍵成功因素
• 競爭程度

合成橡膠輸液幫浦市場：依產品

• 市場概況
• 連續速度合成橡膠輸液泵
• 變速合成橡膠輸液泵

合成橡膠輸液幫浦市場：依應用分類

• 市場概況
• 疼痛管理
• 化療
• 抗生素/抗病毒治療
• 其他

合成橡膠輸液幫浦市場：依最終用途分類

• 市場概況
• 醫院
• 門診手術中心
• 其他

各地區合成橡膠輸液幫浦市場規模

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Baxter（US）
• Fresenius Kabi AG（Germany）
• B. Braun SE（Germany）
• Ambu A/S（Denmark）
• NIPRO（Japan）
• Terumo Corporation（Japan）
• AVNS（US）
• Vygon Group（France）
• Smiths Group plc（UK）
• ICU Medical, Inc.（US）
• Pajunk GmbH（Germany）
• Woo Young Medical Co., Ltd.（South Korea）
• Sapphire Medical（Israel）
• Ace Medical Co., Ltd.（South Korea）
• Eitan Medical（Israel）
• Zyno Medical（US）
• Epic Medical（Singapore）
• Nipro Corporation（Japan）
• Daiken Medical Co., Ltd.（Japan）
• Coopdech（Japan）
• Westmed, Inc.（US）
• Flowonix Medical Inc.（US）

Global Elastomeric Infusion Pumps Market size was valued at USD 638 million in 2022 and is poised to grow from USD 684.57 million in 2023 to USD 1202.87 million by 2031, growing at a CAGR of 7.30% during the forecast period (2024-2031).

The global elastomeric infusion pump market is poised for substantial growth, driven by a confluence of factors that highlight the increasing need for advanced medical delivery systems. A rising number of orthopedic procedures and surgeries, heightened demand for compact, disposable ambulatory elastomeric infusion pumps, and rapid technological advancements are all contributing to market expansion. Notably, the growing prevalence of chronic diseases, particularly diabetes, serves as a primary growth catalyst. Recent statistics from the International Diabetes Federation illustrate the alarming rise in diabetes cases, with projections indicating approximately 643 million adults will be affected by the condition by 2030. Such chronic ailments account for 41 million deaths annually, according to the World Health Organization, emphasizing an urgent need for effective management solutions. Additionally, conditions like osteomyelitis, which reports around 50,000 cases annually in the US, are on the rise, notably among demographics with existing comorbidities such as diabetes and peripheral vascular disease. This burgeoning burden of chronic diseases underscores the critical demand for safe and effective medication delivery through intravenous routes, consequently propelling the elastomeric infusion pump market. As healthcare systems increasingly prioritize improved patient outcomes and the adoption of innovative technologies, the US elastomeric infusion pumps market is expected to achieve a sustainable compound annual growth rate (CAGR) in the forecast period ahead. This trend reflects a significant opportunity for stakeholders in the medical device industry to enhance patient care and address the evolving needs of healthcare providers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Elastomeric Infusion Pumps market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Elastomeric Infusion Pumps Market Segmental Analysis

Global Elastomeric Infusion Pumps Market is segmented by Product, Application, End Use, and region. Based on Product, the market is segmented into Continuous Rate Elastomeric Infusion Pumps, and Variable Rate Elastomeric Infusion Pumps. Based on function, the market is segmented into Pain Management, Chemotherapy, Antibiotic/Antiviral Therapy, and Others. Based on End Use, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Elastomeric Infusion Pumps Market

The escalating prevalence of chronic diseases, including diabetes, cancer, and cardiovascular disorders, is a pivotal market driver for the Global Elastomeric Infusion Pumps market. As healthcare systems prioritize efficient and patient-friendly treatment modalities, elastomeric infusion pumps emerge as a preferred choice due to their ability to deliver medications consistently over extended periods. These devices offer several advantages, such as portability, ease of use, and reduced risk of infection, making them ideal for outpatient settings. Consequently, the growing demand for effective long-term medication management solutions significantly boosts the market's growth potential, highlighting the critical role of elastomeric infusion pumps in modern healthcare.

Restraints in the Global Elastomeric Infusion Pumps Market

The Global Elastomeric Infusion Pumps market is significantly restrained by the growing competition from alternative drug delivery systems, particularly electronic infusion pumps and implantable pumps. These alternatives not only incorporate advanced technological features but also provide more precise drug delivery methods, appealing to healthcare providers and patients alike. As these innovative systems continue to evolve, they pose substantial challenges to the adoption and market penetration of elastomeric infusion pumps. This competitive landscape compels manufacturers to enhance the functionality and efficiency of elastomeric devices or risk becoming obsolete, ultimately hindering market growth in the burgeoning healthcare sector.

Market Trends of the Global Elastomeric Infusion Pumps Market

The global elastomeric infusion pumps market is experiencing a significant upward trend, primarily fueled by the increasing demand for home healthcare and ambulatory care solutions. This shift is driven by an aging population seeking cost-effective treatment options, coupled with advancements in medical technology that enhance the usability of these devices. The portability and user-friendly design of elastomeric infusion pumps allow patients to administer continuous medication infusions in the comfort of their own homes, thereby improving patient satisfaction and outcomes. As healthcare facilities face mounting pressures, the rising adoption of these pumps is set to redefine patient care dynamics and reshape market strategies.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Case study Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Elastomeric Infusion Pumps Market by Product

• Market Overview
• Continuous Rate Elastomeric Infusion Pumps
• Variable Rate Elastomeric Infusion Pumps

Elastomeric Infusion Pumps Market by Application

• Market Overview
• Pain Management
• Chemotherapy
• Antibiotic/Antiviral Therapy
• Others

Elastomeric Infusion Pumps Market by End Use

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Others

Elastomeric Infusion Pumps Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Baxter (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ambu A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NIPRO (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AVNS (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vygon Group (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smiths Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pajunk GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Woo Young Medical Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sapphire Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ace Medical Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eitan Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zyno Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epic Medical (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daiken Medical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coopdech (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Westmed, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flowonix Medical Inc. (US
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments